Sangamo Therapeutics
SGMO
#9893
Rank
$70.42 M
Marketcap
$0.17
Share price
-5.56%
Change (1 day)
-63.04%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $82.4 Million USD

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are $82.4 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$78.86 M-4.33%
2023-12-31$82.43 M-69.19%
2022-12-31$0.26 B-22.8%
2021-12-31$0.34 B-21.44%
2020-12-31$0.44 B115.45%
2019-12-31$0.20 B-8.23%
2018-12-31$0.22 B125.75%
2017-12-31$98.84 M355.57%
2016-12-31$21.69 M-12.5%
2015-12-31$24.79 M-32.21%
2014-12-31$36.57 M91.23%
2013-12-31$19.12 M8.45%
2012-12-31$17.63 M144.82%
2011-12-31$7.2 M1.58%
2010-12-31$7.09 M-54.7%
2009-12-31$15.65 M25.72%
2008-12-31$12.45 M5.74%
2007-12-31$11.77 M66.47%
2006-12-31$7.07 M-36.66%
2005-12-31$11.16 M375.68%
2004-12-31$2.34 M49.46%
2003-12-31$1.57 M-20.7%
2002-12-31$1.98 M-25.75%
2001-12-31$2.66 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$119.70 B 145,176.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$83.31 B 101,009.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$10.83 B 13,044.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
$43.01 B 52,105.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$32.84 B 39,762.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$82.75 B 100,329.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$4.05 B 4,820.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$2.37 B 2,787.03%๐Ÿ‡บ๐Ÿ‡ธ USA